Trials / Conditions / Cocaine Dependence

Cocaine Dependence

187 registered clinical trials studyying Cocaine Dependence — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder NCT05974202	New York State Psychiatric Institute	N/A
Recruiting	Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder NCT07318480	Icahn School of Medicine at Mount Sinai	N/A
Recruiting	Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction NCT06125054	Dr. med. Marcus Herdener	Phase 2
Unknown	Randomized, Double-blind, Placebo-controlled Cannabis Extract x Placebo for Cocaine Addicts NCT06159387	University of Sao Paulo General Hospital	Phase 4
Active Not Recruiting	Clavulanic Acid for the Treatment of Cocaine Use Disorder NCT05562349	Temple University	Phase 2
Unknown	Effect of rTMS on Neurotrophines Levels in CUD NCT05824221	ITAB - Institute for Advanced Biomedical Technologies	N/A
Unknown	Low-Intensity Focused Ultrasound for Cocaine Use Disorder NCT05857852	University of Virginia	N/A
Completed	rTMS for Stimulant Use Disorders NCT04907357	Medical University of South Carolina	N/A
Recruiting	Effect of HF rTMS on Serum BDNF in Cocaine Use Disorder NCT06189690	Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente	N/A
Completed	TDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study NCT04994821	Soterix Medical	Phase 2
Completed	Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid NCT04411914	Temple University	Phase 1
Completed	TDCS for Cocaine Addiction Craving NCT03833583	Soterix Medical	N/A
Completed	Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET NCT03527485	Yale University	N/A
Withdrawn	Rebalancing the Serotonergic System in Cocaine Dependence NCT03266939	Mclean Hospital	Phase 1
Completed	Investigation of Cocaine Addiction Using mGluR5 PET and fMRI NCT03471182	Yale University	Phase 1
Unknown	Transcranial Magnetic Stimulation for Cocaine Addiction NCT03333460	ITAB - Institute for Advanced Biomedical Technologies	N/A
Completed	Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting NCT03662529	Hunter Holmes Mcguire Veteran Affairs Medical Center	N/A
Terminated	Theta-Burst Stimulation as a Treatment for Reducing Cocaine Use NCT02927236	National Institute on Drug Abuse (NIDA)	N/A
Completed	Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study NCT02563769	Temple University	Phase 1
Terminated	Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants NCT02935101	Prof. Dominique de Quervain, MD	Phase 2
Completed	10 Days of Theta Burst Stimulation as a Tool to Treat Cocaine Dependence NCT03238859	Medical University of South Carolina	Phase 2
Completed	Cannabidiol and Cocaine Craving/Dependence NCT02559167	Centre hospitalier de l'Université de Montréal (CHUM)	Phase 2
Completed	Change the Cycle: An RCT to Prevent Injection Initiation NCT02774954	University of Southern California	N/A
Completed	Functional Magnetic Resonance Imaging of N-acetylcysteine in Cocaine Dependence NCT02994875	Yale University	EARLY_Phase 1
Completed	Longitudinal Assessment of Functional Connectivity in Treatment Engaged Cocaine Users NCT03554928	Medical University of South Carolina	—
Completed	Complementary Combination Therapy for Cocaine Dependence NCT02538744	Baylor College of Medicine	Phase 1
Completed	Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients. NCT02255357	New York State Psychiatric Institute	Phase 2 / Phase 3
Completed	Predicting Relapse After Cocaine Inpatient Cessation NCT02416050	Assistance Publique - Hôpitaux de Paris	—
Completed	GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration NCT02302976	Yale University	Phase 1
Completed	Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence NCT01468012	New York State Psychiatric Institute	Phase 2 / Phase 3
Completed	PET Imaging in Cocaine Self Administration NCT02181491	Yale University	N/A
Completed	Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence NCT02111798	Johns Hopkins University	Phase 2 / Phase 3
Withdrawn	A PET Exploration of the Mechanism of Action of Dopamine Beta-hydroxylase Inhibition in Cocaine Addicts NCT02134002	Assistance Publique - Hôpitaux de Paris	Phase 4
Completed	5HT2CR Balance in Brain Connectivity in Cocaine Dependence NCT03921151	Virginia Commonwealth University	Phase 1 / Phase 2
Completed	n-Acetylcysteine and Cocaine NCT02141620	University of Kentucky	EARLY_Phase 1
Terminated	Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO NCT02152670	Yale University	N/A
Completed	Pharmacogenetic Trial of Doxazosin for Treatment of Cocaine Abuse NCT01953432	VA Office of Research and Development	Phase 2
Completed	Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS NCT02124941	Yale University	Phase 1
Withdrawn	D-Serine for Cocaine Dependence Pilot NCT01715051	Theresa Winhusen	Phase 2
Completed	Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse NCT02080819	Virginia Commonwealth University	Phase 2
Completed	A Sequenced Behavioral and Medication Intervention for Cocaine Dependence NCT01986075	New York State Psychiatric Institute	Phase 1 / Phase 2
Completed	Impact of a Non-Drug Choice on Cocaine Reinforcement NCT01906346	Joshua A. Lile, Ph.D.	EARLY_Phase 1
Withdrawn	A Study of Baclofen ER NCT02003664	University of Pennsylvania	Phase 2
Completed	Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use i NCT02018263	Yale University	Phase 1
Completed	Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence NCT01811940	New York State Psychiatric Institute	Phase 2 / Phase 3
Completed	The Effect of Glutamatergic Modulation on Cocaine Self-administration NCT02596022	New York State Psychiatric Institute	Phase 2
Completed	A Multi-Center Trial of Nepicastat for Cocaine Dependence NCT01704196	National Institute on Drug Abuse (NIDA)	Phase 2
Completed	A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocai NCT01846481	Indivior Inc.	Phase 2
Terminated	A Pilot Study of Candesartan as a Treatment for Cocaine Dependence NCT01938664	Baylor College of Medicine	Phase 2
Terminated	A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment NCT01802515	Yale University	N/A
Completed	Impulsivity and Stimulant Administration NCT01978431	Yale University	Phase 1
Withdrawn	Progesterone and Atomoxetine for Cocaine Cessation NCT01741376	University of Minnesota	N/A
Withdrawn	Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics NCT01406522	Midwest Biomedical Research Foundation	Phase 2
Completed	Oxytocin in Cocaine Dependence NCT01573273	Medical University of South Carolina	N/A
Completed	A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence NCT01680887	University of Pennsylvania	Phase 2
Completed	Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence NCT01641159	University of Cincinnati	Phase 2
Completed	Pharmacologic MRI in Cocaine Addiction NCT01652378	University of Texas Southwestern Medical Center	—
Recruiting	Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals NCT02455479	Weill Medical College of Cornell University	Phase 1
Completed	Behavioral Incentives to Increase Exercise in Cocaine Dependent Women NCT01283191	Virginia Commonwealth University	N/A
Terminated	The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence NCT01535937	New York State Psychiatric Institute	Phase 1 / Phase 2
Completed	Exercise as an Adjunctive Treatment for Cocaine Dependent Patients NCT01832649	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	N/A
Completed	Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence NCT01486810	New York State Psychiatric Institute	Phase 1 / Phase 2
Completed	Pramipexole as a Treatment for Cocaine Dependence NCT01651377	Baylor College of Medicine	Phase 1
Completed	Cocaine Use Reduction With Buprenorphine NCT01402492	University of California, Los Angeles	Phase 2 / Phase 3
Completed	Exercise as a Behavioral Treatment for Cocaine Dependence NCT01601743	Baylor College of Medicine	N/A
Completed	PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin NCT01377662	Tong Lee	Phase 2
Completed	A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence NCT01651364	Baylor College of Medicine	Phase 1
Terminated	Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence NCT01490216	University of Minnesota	Phase 1
Completed	Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals NCT01963091	Medical University of South Carolina	Phase 2
Completed	Cognitive Remediation for Cocaine Dependence NCT01393457	The University of Texas Health Science Center, Houston	Phase 2
Completed	Cocaine/Crack and Reduction of Compulsion With Biperiden NCT01251393	Federal University of São Paulo	Phase 3
Unknown	Neuropsychological Rehabilitation on Cocaine/Crack Dependents NCT01914835	University of Sao Paulo General Hospital	N/A
Terminated	Vigabatrin for Cocaine and Alcohol Dependence NCT01335867	University of Pennsylvania	Phase 2
Completed	Psychopharmacology for Cocaine Dependence - Buspirone NCT01267292	The University of Texas Health Science Center, Houston	Phase 2
Completed	Glutamatergic Modulation of Cocaine-related Deficits NCT01790490	New York State Psychiatric Institute	Phase 2
Completed	Progesterone for Postpartum Cocaine Relapse NCT01249274	Yale University	N/A
Completed	Vigabatrin for the Treatment of Cocaine Dependency NCT01281202	Catalyst Pharmaceuticals, Inc.	Phase 2 / Phase 3
Completed	Citalopram for Cocaine Dependence NCT01535573	Joy Schmitz	Phase 2
Completed	Ovarian Hormones and Stress Induced Drug Craving NCT02098434	Medical University of South Carolina	N/A
Completed	HBPL Study of the Impact of the NK1 Antagonist Aprepitant NCT01176591	University of Pennsylvania	Phase 2
Completed	Carvedilol for Psychostimulant Dependence NCT01171183	University of Arkansas	Phase 2
Completed	Modafinil - Escitalopram Study for Cocaine Dependence NCT01601730	Baylor College of Medicine	Phase 1
Completed	Multisite Controlled Trial of Cocaine Vaccine NCT00969878	Baylor College of Medicine	Phase 2
Completed	Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving NCT01151813	University of Pennsylvania	Phase 2
Completed	Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence NCT00223236	University of Texas Southwestern Medical Center	Phase 3
Completed	Cocaine Use Disorder and Cortical Dopamine NCT03349606	University of Pittsburgh	EARLY_Phase 1
Completed	Effect of Zonisamide on Cocaine Reinforcement, Craving, and Relapse NCT01137890	Johns Hopkins University	Phase 1 / Phase 2
Withdrawn	Human Behavioral Pharmacology Laboratory Study of Varenicline's Impact on Cocaine Reinforcement NCT01143857	Jennifer Plebani	Phase 2
Completed	Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patien NCT01134198	New York State Psychiatric Institute	Phase 2 / Phase 3
Completed	Modafinil, Sleep Architecture and Cocaine Relapse NCT01137396	Yale University	Phase 2
Unknown	Repetitive Transcranial Magnetic Stimulation in Symptoms of Attention Deficit Hyperactivity Disorder and Cogni NCT01593982	University of Sao Paulo General Hospital	Phase 2
Unknown	Study of the Effect of Magnetic Stimulation Repetitive Transcranial on Impulsivity in Cocaine Dependence NCT01397266	University of Sao Paulo General Hospital	Phase 2
Completed	Pharmacogenetics of Doxazosin for Cocaine Dependence NCT01145183	Baylor College of Medicine	Phase 2
Completed	Smoking-Cessation and Stimulant Treatment (S-CAST) NCT01077024	University of Cincinnati	Phase 3
Completed	Brain Function and Structure in Cocaine Dependence NCT02080832	Virginia Commonwealth University	Phase 2
Completed	The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine NCT01062945	Baylor College of Medicine	Phase 1
Completed	Measuring Distress Tolerance With Functional MRI NCT01038232	National Institute on Drug Abuse (NIDA)	—
Completed	Abstinence-Linked Money Management Multisite NCT01327586	Yale University	Phase 2
Completed	Effectiveness of Extended Treatment for Drug Dependence (ETDD) in the City Study NCT01153464	University of Pennsylvania	Phase 2
Completed	Effectiveness of Enhanced Treatments for Drug Dependence NCT01153477	University of Pennsylvania	Phase 2
Completed	The Efficacy of Doxazosin for Cocaine Users NCT00880997	Baylor College of Medicine	Phase 1
Completed	Risk Perception in Drug-Dependent Adults With and Without Schizophrenia NCT01031563	National Institute on Drug Abuse (NIDA)	—
Terminated	Brain Glutamate Receptors and Cocaine Dependence NCT00951314	National Institute on Drug Abuse (NIDA)	—
Completed	Treatment of Cocaine Dependence With Lisdexamfetamine NCT00958282	University of Minnesota	Phase 2
Completed	VIVITROL as a Treatment for Cocaine and Alcohol Dependence NCT00777062	University of Pennsylvania	Phase 2
Completed	Brain Imaging Study of the Effects of Modafinil in Cocaine Addiction NCT00701532	Assistance Publique - Hôpitaux de Paris	Phase 3
Completed	Modafinil for Smoked Cocaine Self-Administration NCT01778010	New York State Psychiatric Institute	Phase 2
Completed	Beta-blockade Effects on Memory for Cocaine Craving NCT00830362	Medical University of South Carolina	Phase 2
Completed	Gender and Neural Substrates of Stress and Craving NCT00756925	Medical University of South Carolina	—
Completed	Rivastigmine and Huperzine A as Treatments for Cocaine Dependence NCT01030692	Baylor College of Medicine	Phase 1
Unknown	Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine Dependence NCT00495183	Hospital Universitari Vall d'Hebron Research Institute	Phase 4
Completed	An fMRI Study of SYN115 in Cocaine Dependent Subjects NCT00783276	Virginia Commonwealth University	EARLY_Phase 1
Completed	Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336 in Healthy, Male Subjec NCT00808119	RTI International	Phase 1
Unknown	A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence NCT00737256	Paul Saenger	Phase 2
Completed	New Medication Treatment for Stimulant Dependence NCT00689572	University of Virginia	Phase 2
Completed	Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers NCT00656357	Biotie Therapies Inc.	Phase 1 / Phase 2
Completed	Clinical Neurobiology of Serotonin and Addiction NCT00732901	Virginia Commonwealth University	Phase 2 / Phase 3
Completed	Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients NCT00780702	National Institute on Drug Abuse (NIDA)	Phase 1
Completed	Pharmacotherapy & CM for Opioid and Cocaine Dependence NCT00838981	Yale University	Phase 1 / Phase 2
Completed	Citicoline for Bipolar 1 Disorder and Cocaine Dependence NCT00619723	University of Texas Southwestern Medical Center	Phase 4
Completed	Caffeine and Cocaine NCT00733993	Virginia Commonwealth University	Phase 1 / Phase 2
Completed	Quetiapine for the Reduction of Cocaine Use NCT00631748	Seattle Institute for Biomedical and Clinical Research	N/A
Completed	Progesterone Treatment for Cocaine-dependent Women: A Pilot Study NCT00632099	New York State Psychiatric Institute	Phase 2 / Phase 3
Completed	Vigabatrin for Treatment of Cocaine Dependence NCT00611130	Catalyst Pharmaceuticals, Inc.	Phase 2
Completed	Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence NCT00713583	The University of Texas Health Science Center, Houston	Phase 2
Terminated	Effects of Propranolol on Responses to Drug-Related Imagery Scripts NCT00688805	National Institute on Drug Abuse (NIDA)	Phase 1
Completed	Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependenc NCT00553319	New York State Psychiatric Institute	Phase 2 / Phase 3
Completed	Chantix for Treating Cocaine Dependence NCT00567008	University of Pennsylvania	Phase 2
Unknown	Treating Cocaine Abuse: A Behavioral Approach NCT01822327	University of Vermont	Phase 2
Completed	A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction NCT00567814	Embera NeuroTherapeutics, Inc.	N/A
Completed	Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse NCT00809835	Yale University	Phase 2
Unknown	Pharmacotherapy for HIV+ Stimulant Dependent Individuals NCT00599573	University of Virginia	N/A
Completed	Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues NCT00585520	Yale University	Phase 1
Completed	Cocaine Withdrawal and Pharmacotherapy Response NCT00566969	Yale University	N/A
Completed	Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients NCT00577005	Yale University	Phase 2
Completed	Effectiveness of Extended Treatments for Drug Dependence NCT00685659	University of Pennsylvania	N/A
Completed	Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence NCT00527683	NYU Langone Health	Phase 2
Completed	Impulsivity, Neural Deficits and Cocaine Addiction NCT00744601	University of Texas Southwestern Medical Center	—
Completed	Disulfiram for Cocaine Abuse NCT00395850	University of Arkansas	Phase 2
Completed	Efficacy of Varenicline in Methadone-Stabilized Cocaine Users NCT00567320	Yale University	N/A
Unknown	Novel Pharmacotherapy for Dual Dependence NCT00448825	Bankole Johnson	Phase 3
Completed	Clinical Trial of Topiramate for Cocaine Addiction NCT00685178	Johns Hopkins University	Phase 2
Completed	A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence NCT00421603	New York State Psychiatric Institute	Phase 2
Completed	Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients. NCT00593125	Yale University	Phase 2
Completed	Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence NCT00385268	University of Pennsylvania	Phase 2
Completed	Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior NCT00368290	Kyle Kampman	Phase 2
Completed	Modafinil, Sleep, and Cognition in Cocaine Dependence NCT00582491	Yale University	N/A
Completed	Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence NCT00376558	New York State Psychiatric Institute	N/A
Completed	Agonist Replacement Therapy for Cocaine Dependence NCT00697138	University of Kentucky	Phase 1
Completed	Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression NCT00249444	New York State Psychiatric Institute	Phase 2
Terminated	Effects of Vigabatrin on Cocaine Self-Administration NCT00373581	New York State Psychiatric Institute	Phase 2
Completed	Valproate Efficacy in Cocaine-Bipolar Comorbidity NCT00240110	University of Miami	Phase 1 / Phase 2
Completed	Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine Dependency NCT00280293	University of Texas Southwestern Medical Center	Phase 4
Completed	Clinical Efficacy of Sertraline Augmented With Gabapentin in Depressed, Recently Abstinent Cocaine-dependent H NCT00654953	University of Arkansas	Phase 2
Completed	Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1 NCT00218491	Medical University of South Carolina	Phase 2
Completed	An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence NCT00223210	University of Texas Southwestern Medical Center	Phase 4
Completed	A Placebo-Controlled Double-Blind Combined Treatment of Modafinil and CBT for Cocaine Dependence NCT00344565	Research Foundation for Mental Hygiene, Inc.	Phase 2
Recruiting	Substance Abuse Pre-Treatment Screening Study NCT00439049	The University of Texas Health Science Center, Houston	—
Completed	Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects NCT00322309	Boston University	Phase 2
Completed	Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active NCT00385801	Massachusetts General Hospital	Phase 2
Completed	FMRI of Stress and Addictive Disorders NCT01558973	Yale University	—
Unknown	Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence NCT00123383	The University of New South Wales	Phase 2
Completed	Metabolic Effects of Cocaine NCT00451230	National Institute on Drug Abuse (NIDA)	N/A
Completed	Reward Processing in Cocaine Addiction NCT01036074	National Institute on Drug Abuse (NIDA)	—
Completed	Vouchers vs. Prizes for Cocaine-Dependent Methadone Patients - 2 NCT00249535	UConn Health	N/A
Completed	Pharmacogenetics of Disulfiram for Cocaine NCT00149630	Baylor College of Medicine	Phase 2
Completed	Long Term Maintenance of Drug Abstinence NCT00842517	Treatment Research Institute	Phase 1
Completed	Topiramate for Alcohol and Cocaine Dependence NCT00167245	Kyle Kampman	Phase 2
Completed	Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction - 1 NCT00218387	Medical University of South Carolina	Phase 2
Terminated	Prazosin for ETOH or Cocaine Craving NCT00240227	US Department of Veterans Affairs	N/A
Completed	Enhanced and Attendance-based Prize CM in Community Settings NCT00606853	UConn Health	N/A
Completed	Combined Treatment for Cocaine-Alcohol Dependence - 1 NCT00218569	The University of Texas Health Science Center, Houston	Phase 2
Completed	Gender Differences in Response to Cues in Cocaine Dependence NCT00969943	Medical University of South Carolina	—
Completed	Therapeutic Cocaine Vaccine: Human Laboratory Study NCT00965263	New York State Psychiatric Institute	Phase 2
Completed	A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence NCT00227123	University of Texas Southwestern Medical Center	N/A
Completed	Cost Effective Treatment for Dually Diagnosed Homeless NCT00368524	University of Alabama at Birmingham	N/A
Completed	Serotonin, Impulsivity, and Cocaine Dependence Treatment NCT00297505	National Institute on Drug Abuse (NIDA)	Phase 2
Completed	Integrated Treatment for Cocaine and Mood Disorders - 1 NCT00227812	National Institute on Drug Abuse (NIDA)	Phase 2
Completed	Disulfiram for Cocaine Abuse in Buprenorphine Treatment NCT00913484	Yale University	Phase 2
Completed	PET Assays of Striatal Dopamine Marker in Cocaine Craving NCT01036516	National Institute on Drug Abuse (NIDA)	—
Completed	Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence - 1 NCT00218660	University of Pennsylvania	Phase 3
Completed	Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1 NCT00061087	New York State Psychiatric Institute	Phase 2 / Phase 3
Completed	Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence NCT00167232	University of Pennsylvania	Phase 3
Completed	Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2 NCT00249457	Johns Hopkins University	N/A
Completed	Behavioral Treatment for Cocaine Dependent Women NCT00914381	Yale University	Phase 2
Terminated	First in Humans Study of JDTic NCT01431586	RTI International	Phase 1
Completed	Effectiveness and Costs of Enhanced Cocaine Treatments NCT00167258	University of Pennsylvania	Phase 2